Profhilo It is the first stabilised hyaluronic acid (HA) based product which is manufactured without the use of chemical cross-linking agents (BDDE) and is used for skin remodelling and treating skin laxity, not for just filling lines and wrinkles. It delivers dramatic improvement in tissue quality, even in challenging areas, and is complementary to other aesthetic treatments and dermal filler procedures.
It is considered to be safe, effective and “a true breakthrough” in anti-ageing medicine.
What does it contain
The formulation of HA with different molecular weights contained in
PROFHILO is based on a concept of Hydrolift® Action. This innovative approach is aimed at counteracting the physiological reduction of HA in the skin, restoring hydration, elasticity and skin tone, by associating, in a synergistic way, deep hydration with the mechanical action of lifting the skin.
Is a skin test required before the treatment?
No allergy test needed
Is it temporary or permanent
Hyaluronic acid is completely broken down within the skin leaving no trace.
Should be used by
Trained members of the medical profession only.
Which areas can be treated
Profhilo is indicated in areas affected by skin laxity such as the malar and submalar areas of the face, cheek and jowls. Since the launch, PROFHILO has proven to be much appreciated for its characteristics of safety, high spreadability and cohesivity (ability to stay together). These qualities have been shown to be very effective in areas typically considered difficult to treat with traditional injectable products such as the temples, forehead, hands, inner arms and neck to mention a few.
How long will the results last
Patients can expect increased firmness, elasticity and an overall improved quality of the skin with the effects lasting six months.
How many treatments will I need
Two treatments sessions are usually recommended initially, with a 1-month interval in between. Top ups and maintenance treatments can then be prescribed by your practitioner according to your body’s response to treatment.